These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15533852)

  • 21. Being specific about race-specific medicine.
    Kahn J; Sankar P
    Health Aff (Millwood); 2006; 25(5):w375-7. PubMed ID: 16912052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The paradox of race in the Bidil debate.
    Crawley L
    J Natl Med Assoc; 2007 Jul; 99(7):821-2. PubMed ID: 17668653
    [No Abstract]   [Full Text] [Related]  

  • 23. Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients.
    Ellison GT; Kaufman JS; Head RF; Martin PA; Kahn JD
    J Law Med Ethics; 2008; 36(3):449-57. PubMed ID: 18840235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Ethnic drugs".
    Kahn J
    Hastings Cent Rep; 2005; 35(1):1 p following 48. PubMed ID: 15799501
    [No Abstract]   [Full Text] [Related]  

  • 25. Medicalisation of race.
    Duster T
    Lancet; 2007 Feb; 369(9562):702-4. PubMed ID: 17321318
    [No Abstract]   [Full Text] [Related]  

  • 26. Race and a heart drug.
    Peota C
    Minn Med; 2005 Mar; 88(3):11. PubMed ID: 15852585
    [No Abstract]   [Full Text] [Related]  

  • 27. F.D.A. approves a heart drug for African-Americans.
    Saul S
    N Y Times Web; 2005 Jun; ():C2. PubMed ID: 15981400
    [No Abstract]   [Full Text] [Related]  

  • 28. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.
    Carson P; Ziesche S; Johnson G; Cohn JN
    J Card Fail; 1999 Sep; 5(3):178-87. PubMed ID: 10496190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gray area for new heart failure drug. Although the FDA approved BiDil for blacks with heart failure, it may work in anyone.
    Harv Heart Lett; 2005 Nov; 16(3):1-2. PubMed ID: 16363036
    [No Abstract]   [Full Text] [Related]  

  • 30. BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.
    Bibbins-Domingo K; Fernandez A
    Ann Intern Med; 2007 Jan; 146(1):52-6. PubMed ID: 17200222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
    Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
    Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dilemmas With Race and Heart Failure Treatment.
    Butler J; Konstam MA
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27707751
    [No Abstract]   [Full Text] [Related]  

  • 33. Postcards: race and medicine in the 21st century.
    Tutton R
    Br J Gen Pract; 2004 Sep; 54(506):716-7. PubMed ID: 15558866
    [No Abstract]   [Full Text] [Related]  

  • 34. Isosorbide dinitrate and hydralazine in blacks with heart failure.
    Chow AY
    N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15761997
    [No Abstract]   [Full Text] [Related]  

  • 35. F.D.A. panel approves heart remedy for blacks.
    Saul S
    N Y Times Web; 2005 Jun; ():C4. PubMed ID: 15981396
    [No Abstract]   [Full Text] [Related]  

  • 36. BiDil: from another vantage point.
    Puckrein G
    Health Aff (Millwood); 2006; 25(5):w368-74. PubMed ID: 16912053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Race, pharmacogenomics, and marketing: putting BiDil in context.
    Kahn J
    Am J Bioeth; 2006; 6(5):W1-5. PubMed ID: 16997802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel heart failure drug may offer options for you.
    Heart Advis; 2005 Sep; 8(9):2. PubMed ID: 16637097
    [No Abstract]   [Full Text] [Related]  

  • 39. BiDil for heart failure.
    Med Lett Drugs Ther; 2005 Sep; 47(1218):77-8. PubMed ID: 16186789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Special treatment": BiDil, Tuskegee, and the logic of race.
    Reverby SM
    J Law Med Ethics; 2008; 36(3):478-84. PubMed ID: 18840239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.